Discontinued — last reported Q2 '22
Edison International Short-Term Borrowings decreased by 48.0% to $1.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 24740.0%, from $5.00M to $1.24B. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows relatively stable performance with a -0.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.82B | $3.04B | $2.35B | $2.05B | $1.99B | $3.01B | $2.02B | $1.65B | $1.16B | $1.01B | $1.08B | $774.00M | $1.51B | $568.00M | $998.00M | $5.00M | $700.00M | $1.88B | $2.39B | $1.24B |
| QoQ Change | — | +7.8% | -22.6% | -13.0% | -3.1% | +51.7% | -33.1% | -18.4% | -29.4% | -13.4% | +7.2% | -28.1% | +94.4% | -62.3% | +75.7% | -99.5% | >999% | +168.4% | +27.2% | -48.0% |
| YoY Change | — | — | — | — | -29.6% | -1.0% | -14.4% | -19.7% | -41.5% | -66.6% | -46.6% | -52.9% | +29.6% | -43.5% | -7.3% | -99.4% | -53.5% | +230.8% | +139.5% | >999% |